Company · Ownership research

LEXICON PHARMACEUTICALS, INC. LXRX

CIK 0001062822

Form 4 transactions dated Nov 1, 2023 to Nov 15, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 75 rows; the complete set is available through the API.

Insider filings on file run through Nov 9, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $3.08M
Sold: $0.00

Nov 1, 2023 – Nov 9, 2026
Available records · partial months are marked ·

Insiders in this window

20269 of 9 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Nov 6, 2026	Exton Michael Chief Executive Officer · Director	Purchase	$50.00K 30,064 shares bought	10.07% added Direct holding	▾
Feb 25, 2026	DEBBANE RAYMOND Director	Purchase	$2.98K 2,000 shares bought	0.11% added Direct holding	▾
Feb 23, 2026	DEBBANE RAYMOND Director	Purchase	$147.00K 100,000 shares bought	5.54% added Direct holding	▾
Feb 20, 2026	DEBBANE RAYMOND Director	Purchase	$147.79K 100,000 shares bought	5.87% added Direct holding	▾
Feb 19, 2026	DEBBANE RAYMOND Director	Purchase	$71.97K 50,000 shares bought	3.02% added Direct holding	▾
Feb 18, 2026	DEBBANE RAYMOND Director	Purchase	$176.47K 133,688 shares bought	8.79% added Direct holding	▾
Feb 17, 2026	DEBBANE RAYMOND Director	Purchase	$100.54K 76,857 shares bought	5.32% added Direct holding	▾
Feb 13, 2026	DEBBANE RAYMOND Director	Purchase	$75.88K 57,952 shares bought	4.18% added Direct holding	▾
Feb 2, 2026	DEBBANE RAYMOND · Artal Group S.A. · Artal International S.C.A. · Westend S.A. · Stichting Administratiekantoor Westend · Artal International Management S.A. · Siren, L.L.C. · Invus Global Management, LLC · Artal Participations S.a r.l. Director	Purchase	$2.00M 1,538,462 shares bought	Unavailable Indirect holding	▾

Showing 9 / 9 record groups in 2026. The complete set is available through the API.

LEXICON PHARMACEUTICALS, INC. · LXRX

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 9 of 9 purchase / sale groups and 30 of 75 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"LXRX","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.